(Q34107294)

31 July 2017

1 reference

title

Does differing metabolism by cytochrome p450 have clinical importance? (English)

1 reference

31 July 2017

Davidson MH

1

1 reference

31 July 2017

1 January 2000

1 reference

Current Atherosclerosis Reports

31 July 2017

1 reference

31 July 2017

2

1 reference

31 July 2017

14-19

1 reference

31 July 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-000-0090-4

31 July 2017

0 references

cites work

Rational assessment of the interaction profile of cerivastatin supports its low propensity for drug interactions

1 reference

12 December 2020

The fate of naringin in humans: a key to grapefruit juice-drug interactions?

1 reference

12 December 2020

Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses

1 reference

12 December 2020

Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial

1 reference

12 December 2020

QT interval prolongation and torsades de pointes due to erythromycin lactobionate

1 reference

12 December 2020

Interaction between grapefruit juice and midazolam in humans.

1 reference

12 December 2020

Lovastatin and rhabdomyolysis

1 reference

12 December 2020

Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin

1 reference

12 December 2020

Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.

1 reference

12 December 2020

Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy

1 reference

12 December 2020

Low-dose simvastatin for the treatment of hypercholesterolaemia in recipients of cardiac transplantation

1 reference

12 December 2020

Newer antidepressants and the cytochrome P450 system

1 reference

12 December 2020

Influence of pharmacogenetics on drug disposition and response

1 reference

12 December 2020

The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients

1 reference

12 December 2020

Mibefradil--a new calcium-channel blocker

1 reference

12 December 2020

Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations

1 reference

12 December 2020

Altered disposition of pravastatin following concomitant drug therapy with cyclosporin A in transplant recipients

1 reference

12 December 2020

Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice

1 reference

12 December 2020

Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved

1 reference

12 December 2020

Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment

1 reference

12 December 2020

Combination of pravastatin and cyclosporin in transplant patients

1 reference

12 December 2020

Recent advances: the cytochrome P450 enzymes.

1 reference

12 December 2020

Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia

1 reference

12 December 2020

The interaction of diltiazem with lovastatin and pravastatin

1 reference

12 December 2020

Rhabdomyolysis associated with lovastatin and erythromycin use.

1 reference

12 December 2020

Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients

1 reference

12 December 2020

Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole

1 reference

12 December 2020

Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine

1 reference

12 December 2020

Update: clinically significant cytochrome P-450 drug interactions

1 reference

12 December 2020

Efficacy and Tolerability of Low-dose Simvastatin and Niacin, Alone and in Combination, in Patients With Combined Hyperlipidemia: A Prospective Trial

1 reference

12 December 2020

Azithromycin and terfenadine: lack of drug interaction.

1 reference

12 December 2020

10.1007/S11883-000-0090-4

Identifiers

DOI

1 reference

PubMed ID

11122720

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

11122720